Anatomical distribution of disease in pN1 prostate cancer with BCR post‐RP: A PSMA‐PET/CT‐based analysis

Documenti analoghi

• Omission of contralateral biopsies in unilateral MRI‐suspicious prostate cancer has minimal impact on clinical risk assessment
  di: Stijn M. van den Bosch, et al.
  Pubblicazione: (2026)
• Hospital variation in the treatment of cT1a renal cancer
  di: Cato Caroline Bresser, et al.
  Pubblicazione: (2026)
• Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
  di: Jeremy Cheng, et al.
  Pubblicazione: (2025)
• PSMA PET/CT findings in high‐risk biochemical recurrence after local treatment of prostate cancer
  di: Nicole Handa, et al.
  Pubblicazione: (2025)
• A population‐based analyses of the evolving management of cN1M0 prostate cancer in the PSMA‐PET era
  di: Jennifer Ward, et al.
  Pubblicazione: (2025)